Skip to Top navigation
Skip to Content
Dr. Anand Saggar

Dr. Anand Saggar - MBBS, CCST, FRCP

Medical Genetic Specialist

A | A | A
07970 886663

Publications And News



  • Saggar AK and Bittles AH. Consanguinity and Child Health. Paediatrics and Child Health. In press. 2008
  • Griffith E, Walker S, Martin CA, Vagnarelli P, Stiff T, Vernay B, Al Sanna N, Saggar A, Hamel B, Earnshaw WC, Jeggo PA, Jackson AP, O'Driscoll M. Mutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signaling. Nat Genet. 2008; 40(2):232-6. Epub 2007 Dec 23
  • Davies DM, Johnson SR, Tattersfield AE, Kingswood JC, Cox JA, McCartney DL, Doyle T, Elmslie F, Saggar A, de Vries PJ, Sampson JR. Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis. N Engl J Med. 2008; 10;358(2):200-3.
  • Doulton TW, Saggar-Malik AK, He FJ, Carney C, Markandu ND, Sagnella GA, MacGregor GA. The effect of sodium and angiotensin-converting enzyme inhibition on the classic circulating renin-angiotensin system in autosomal-dominant polycystic kidney disease patients. J Hypertens. 2006 May; 24(5):939-45.
  • Patel U, Simpson E, Kingswood JC, Saggar-Malik AK. Tuberose sclerosis complex: analysis of growth rates aids differentiation of renal cell carcinoma from atypical or minimal-fat-containing angiomyolipoma. Clin Radiol. 2005 Jun;60(6):665-73; discussion 663-4.
  • Whittock NV, Izatt L, Mann A, Homfray T, Bennett C, Mansour S, Hurst J, Fryer A, Saggar A, Barwell JG, Ellard S, Clayton PT.  Novel mutations in X-linked dominant chondrodysplasia punctata (CDPX2).  The Soc for Investig Derm. 2003, October, 121 (4) 939 – 942.
  • Rossetti S, Chauveau D, Kubly V, Slezak JM, Saggar-Malik AK, Pei Y, Ong AC, Stewart F, Watson ML, Bergstralh EJ, Winearls, CG, Torres VE, Harris PC.  Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype.  Lancet 2003 June; 361 (9376) 2196-201.
  • Dong YB, Plange-Rhule J Owusu I, Micah F, Eastwood JB, Carter ND, Saggar-Malik AK, Cappuccio FP, Jeffery S.  T594M mutation of the beta-subunit of the epithelial sodium channel in Ghanaian populations from Kumasi and London and a possible association with hypertension.  Genet Test. 2002 Spring; 6(1):63-65.
  • Rosseti S, Chauveau D, Walker D Saggar-Malik AK, Winearls CG, Torres VE, Harris PC.  A complete mutation screen of the ADPKD genes by DHPLC.  Kidney Int. 2002 May;61(5):1588-1599.    
  • Afzal AR, Florencio RN, Taylor R, Patton MA, Saggar-Malik AK, Jeffery S.  Novel mutations in the duplicated region of the polycystic kidney disease 1 (PKD1) gene provides supporting evidence for gene conversion. Genet Test. 2000;4(4):365-370.
  • Saggar-Malik AK, Afzal AR, Swissman JS, Bland M, Sagnella GA, Eastwood JB, MacGregor GA, Jeffery S.  Lack of association of ACE/angiotensinogen genotype with renal function in autosomal dominant polycystic kidney disease.  Genet Test. 2000; 4(3):299-303.
  • Hateboer N, Torra R, Estivill E,  Bogdanova N, Davies F, Lazarou L, v Dijk M, Breuning M, Saggar-Malik A, Jeffery S, San Millan J L,  Martinez I, Walker R,  Holmans P, Ravine D. Location of mutations within the PKD2 gene influences outcome. Kidney International, 2000. 57, 1444-1451
  • Jeffery S Crosby A Plange-Rhule, J., Amoah-Danquah J., Acheampong JW., Eastwood J., Saggar-Malik AK. Evidence from a Ghanian population of known African descent to support the proposition that haemochromatosis is a Caucasian disorder.  Genetic testing 1999 3,375-378
  • Jeffery S.,  Saggar-Malik AK.,  Crosby A.,  Bland M.,  Eastwood J.,  Amoah-Danquah J.,  Acheampong JW., Plange-Rhule, J. A dominant relationship between the ACE-D allele and serum ACE levels in a Ghanaian population J.Med Genet 1999. 36 869-870.
  • Afzal. A. R., Hand, M., Ternes-Pereira, E., Saggar-Malik, AK., Taylor, R., Jeffery, S. Novel Mutations in the 3’ region of the polycystic kidney disease 1 (PKD1) gene.   Human Mutation. 1999. 105, 648-653.

  • Plange-Rhule, J, Phillips, R, Acheampong, JW, Saggar-Malik, AK, Eastwood. J, Cappuccio, FP. Hypertension and renal failure in Kumasi, Ghana. 1999. J Human Hypertension, 13, 37-40
  • Hateboer, N,  v Dijk M, Bogdanova N, Coto E, Jeffery S, Saggar-Malik AK, San Milan J L, Torra R, Breuning M, Holmans P, Ravine D. Polycystic Kidney Disease types 1 and 2:a comparison of phenotypes. Lancet 9 January 1999
  • Jeffery S, Economides DL., Saggar-Malik AK, MacDermott KD, Apparent normalisation of fetal renal size in autosomal dominant polycystic kidney disease. Clinical Genetics 1998. 53,303-307.
  • Sagnella, GA, Saggar-Malik, AK, Buckley, MG, Markandu, ND, Eastwood, JB, MacGregor, GA. Association between atrial natriuretic peptide and cyclic GMP in hypertension and in chronic renal failure.  Clinica Chemica Acta 275, 9-18, 1998
  • MacDermott KD, Saggar-Malik AK, Economides DL, Jeffery S.  Prenatal diagnosis for autosomal dominant polycystic kidney disease (PKD1) presenting in utero and prognosis for very early onset disease J Med Genet 35 1 13-16, 1998
  • Weston, BS, Jeffery, S, Jeffrey I, Sharaf, FA, Carter N, Saggar-Malik AK, Price, RG. Polycystin expression during embryonic development of human kidney in adult tissues and ADPKD tissue. Histochem J 29, 847-856. 1997
  • Saggar-Malik AK, Markandu, ND, MacGregor, GA, Cappuccio FP. Case report: Moderate salt restriction for the management of hypertension and hypercalciuria. J Human Hypertens 10, 811-813. 1996
  • Saggar-Malik AK. Making the change. A guide to changing antihypertensive therapy in the elderly. (Editorial) Geriatrics, 10, 1996
  • Saggar-Malik AK and Patton, M. A. Original contributions by medical students. BMJ 1997
  • Buckley MG, Saggar-Malik AK, Markandu ND, Sagnella GA, MacGregor GA. Effects of changes in dietary sodium intake on plasma brain natriuretic peptide levels in patients with autosomal dominant polycystic kidney disease. J Hum Hyperten, 10, 1996
  • Jeffery S, Morgan S, WarmingtonVJ, MacGregor GA, Saggar-Malik AK. A family with autosomal dominant polycystic kidney disease not linked to 4q21-23 J Med Genet 1995, 32 493-94
  • Bath PMW, Saggar-Malik AK, MacDougall I, Eastwood JB, MacGregor1995. Increased platelet volume in autosomal dominant polycystic kidney disease Platelets 1995 6 (6): 336-339
  • Jeffery, S, Saggar-Malik AK, Morgan, S, Eastwood, JB, Patton, M. Genetic analysis of 20 families with autosomal dominant polycystic kidney disease from the South West Thames Region. Clinical Genetics, 1995; 77, (6) 290-4
  • Mathiu I, Saggar-Malik AK, Carter N. Characterisation and expression of CA-4 receptor activity in EaHY 926 (UveX) endothelial cell line. Biochemical Transactions and Proceedings 13, 635, 1995
  • Buckenham T, Saggar-Malik AK. Alcohol for parenchymal cysts. Australasian Radiology 1994 38: 85-86.
  • Saggar-Malik AK, Jeffery, S. and Patton, M. A. Autosomal dominant polycystic kidney disease. (Editorial) British Medical Journal, 308: 1183-1184, 1994.
  • Saggar-Malik AK, Missouris, C. G., Gill, J. S., Singer, D. R. J., Markandu, N. D. and MacGregor, G. A. Left ventricular mass in normotensive subjects with autosomal dominant polycystic kidney disease. British Medical Journal 1994 309: 1617-1618.
  • Jeffery, S., Saggar-Malik AK, Morgan, S. and MacGregor, G. A. A family with autosomal dominant polycystic kidney disease not linked to chromosome 16p 13.3. Clinical Genetics, 44: 173-176 1994
  • Stenvinkel P, Saggar-Malik A.K. Alvestrand A. Renal haemodynamics and tubular sodium handling following volume expansion with sodium chloride (NaCl) and glucose in healthy humans. Scand J Lab Invest  52: 837-846, 1992
  • Stenvinkel P, Saggar-Malik AK, Wahrenberg H, Diczfalusy U, Bolinder J, Alvestrand A Impaired intrarenal dopamine production following intravenous sodium chloride infusion in insulin-dependent (Type 1) diabetes mellitus. Diabetologia, 34, 114-118, 1991
  • Cundy TF Butler J, Pope RM, Saggar-Malik AK, Wheeler MJ, Williams R Amenorrhoea in Women with Non alcoholic Chronic Liver Disease. Gut 32, 2 p 202-206. 1991

Book Chapters

  • Saggar A. Inherited Renal dieases. In: Horizons in Medicine 17. Updates in major medical clinical advances. Ed Dorian Haskard. Royal College of Physicians. London, 2005
  • Saggar Malik AK, Somlo S.  Autosomal dominant polycystic kidney disease. In: The Genetics of Renal Disease.  Eds. Flinter F, Maher E, Saggar-Malik AK. Oxford University Press, Oxford.2003.
  • Saggar Malik AK.  Cystic kidney disease. In: The Genetics of Renal Disease.  Eds. Flinter F, Maher E, Saggar-Malik AK. Oxford University Press, Oxford.  2003.
  • Saggar Malik AK.  Gene therapy in renal disease. In: The Genetics of Renal Disease.  Eds. Flinter F, Maher E, Saggar-Malik AK. Oxford University Press, Oxford.  2003.
  • Saggar-Malik AK and Jeffery S. Gene structure and regulation and laboratory techniques. In Inherited disorders of the kidney, Ed Morgan SA and Gruenfeld JP. Oxford University Press, Oxford. 1998
  • Saggar-Malik AK, Pettitt K. Autosomal dominant polycystic kidney disease: An information booklet for patients and their families. St George's Medical  School, London. 1996
  • Saggar-Malik, AK. Cardiovascular risk factors in the ethnic minorities. (Bilingual Booklet). Wandsworth Borough Council,  London, 1993
  • Saggar-Malik, AK, Cappuccio, FP.  Potassium supplements and potassium-sparing diuretics. A review and guide to appropriate use. Drugs, 46, (6), 986-1008 1993

Edited Books

  • Flinter F, Maher E , Saggar-Malik AK.  The Genetics of Renal Disease, Oxford monographs on medical genetics, 48. Oxford University Press, Oxford.2003.